» Articles » PMID: 23574039

Developmental Vulnerability of Synapses and Circuits Associated with Neuropsychiatric Disorders

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2013 Apr 12
PMID 23574039
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Psychiatric and neurodegenerative disorders, including intellectual disability, autism spectrum disorders (ASD), schizophrenia (SZ), and Alzheimer's disease, pose an immense burden to society. Symptoms of these disorders become manifest at different stages of life: early childhood, adolescence, and late adulthood, respectively. Progress has been made in recent years toward understanding the genetic substrates, cellular mechanisms, brain circuits, and endophenotypes of these disorders. Multiple lines of evidence implicate excitatory and inhibitory synaptic circuits in the cortex and hippocampus as key cellular substrates of pathogenesis in these disorders. Excitatory/inhibitory balance--modulated largely by dopamine--critically regulates cortical network function, neural network activity (i.e. gamma oscillations) and behaviors associated with psychiatric disorders. Understanding the molecular underpinnings of synaptic pathology and neuronal network activity may thus provide essential insight into the pathogenesis of these disorders and can reveal novel drug targets to treat them. Here, we discuss recent genetic, neuropathological, and molecular studies that implicate alterations in excitatory and inhibitory synaptic circuits in the pathogenesis of psychiatric disorders across the lifespan.

Citing Articles

Analysis of Posttraumatic Stress Disorder Gene Expression Profiles in a Prospective, Community-Based Cohort.

Dahrendorff J, Wani A, Keller T, Armstrong D, Qu A, Wildman D Hum Biol. 2024; 95(1):33-47.

PMID: 39619252 PMC: 11606054. DOI: 10.1353/hub.2017.a935047.


The TrkC-PTPσ complex governs synapse maturation and anxiogenic avoidance via synaptic protein phosphorylation.

Khaled H, Ghasemi Z, Inagaki M, Patel K, Naito Y, Feller B EMBO J. 2024; 43(22):5690-5717.

PMID: 39333774 PMC: 11574141. DOI: 10.1038/s44318-024-00252-9.


Electrical Synapses Mediate Embryonic Hyperactivity in a Zebrafish Model of Fragile X Syndrome.

Miles K, Barker C, Russell K, Appel B, Doll C J Neurosci. 2024; 44(31).

PMID: 38969506 PMC: 11293453. DOI: 10.1523/JNEUROSCI.2275-23.2024.


The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia.

Uliana D, Lisboa J, Gomes F, Grace A Biochem Pharmacol. 2024; 228:116298.

PMID: 38782077 PMC: 11410545. DOI: 10.1016/j.bcp.2024.116298.


Identification of Neurotransmission and Synaptic Biological Processes Disrupted in Autism Spectrum Disorder Using Interaction Networks and Community Detection Analysis.

Vilela J, Martiniano H, Marques A, Santos J, Asif M, Rasga C Biomedicines. 2023; 11(11).

PMID: 38001974 PMC: 10668950. DOI: 10.3390/biomedicines11112971.


References
1.
Demichele-Sweet M, Lopez O, Sweet R . Psychosis in Alzheimer's disease in the national Alzheimer's disease coordinating center uniform data set: clinical correlates and association with apolipoprotein e. Int J Alzheimers Dis. 2011; 2011:926597. PMC: 3065057. DOI: 10.4061/2011/926597. View

2.
Mei L, Xiong W . Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci. 2008; 9(6):437-52. PMC: 2682371. DOI: 10.1038/nrn2392. View

3.
Rakic P, Bourgeois J, Eckenhoff M, Zecevic N, Goldman-Rakic P . Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science. 1986; 232(4747):232-5. DOI: 10.1126/science.3952506. View

4.
Steiner H, Blum M, Kitai S, Fedi P . Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat. Exp Neurol. 1999; 159(2):494-503. DOI: 10.1006/exnr.1999.7163. View

5.
Lisman J, Grace A . The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron. 2005; 46(5):703-13. DOI: 10.1016/j.neuron.2005.05.002. View